Image

Detection of Cancer in Breath Samples by Trained Detection Dogs

Detection of Cancer in Breath Samples by Trained Detection Dogs

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to show that trained detection dogs can identify breast, lung, prostate or colorectal cancer by sniffing masks containing breath samples. In this study, individuals who will undergo cancer screening at an integrated cancer prevention center or biopsy for a suspected malignancy, will be asked to provide a breath sample by breathing into a surgical mask. The mask will then be sent to the laboratory, where trained detection dogs will determine if the person who provided the mask has breast, lung, prostate or colorectal cancer or if the person does not have these types of cancer. The results provided by the dogs will be compared to the actual cancer screening results or biopsy results in order to determine the accuracy of cancer detection by the trained dogs.

Eligibility

Inclusion Criteria:

  1. Men and women aged 18 and over.
  2. Signing an informed consent prior to performing the test.
  3. Intended to undergo screening tests for cancer detection.
  4. Did not smoke 2 hours before providing the breath sample
  5. Did not drink coffee in the hour before providing the breath sample
  6. Did not drink an alcoholic beverage in the hour prior to providing the breath sample.
  7. Did not eat food in the hour before providing the breath sample.

Exclusion Criteria:

  1. Was diagnosed with cancer or was treated for cancer in the seven years preceding the study, excluding non-metastatic skin tumors that were surgically removed.
  2. Undergoing chemotherapy for any purpose.
  3. Pregnant or breastfeeding
  4. Had a medical procedure in the chest cavity and/or airways in the two weeks prior to providing the breath sample that may interfere with the ability to correctly provide a breath sample.
  5. Has a Helicobacter pylori infection.
  6. Has a peptic ulcer disease.
  7. Has a flare-up of an inflammatory bowel disease (Crohn's disease/ulcerative colitis).
  8. has an active infection, such as COVID-19, abscess, bacterial/viral/fungal infection, pneumonia, laryngitis, intestinal inflammation, active tuberculosis infection.

Study details
    Breast Cancer
    Colorectal Cancer
    PROSTATE CANCER
    Lung Cancer

NCT06255041

SpotitEarly

20 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.